Related Experiment Video

Updated: Sep 27, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Meizothrombin, an intermediate of prothrombin cleavage potently activates renal carcinoma cells by interaction with

R Kaufmann1, U Junker, M Schilli-Westermann

  • 1Research Laboratory, Department of General and Visceral Surgery, Institute of Immunology, Medical Faculty at the Friedrich Schiller University Jena, Research Center Lobeda, Germany. roland.kaufmann@med.uni-jena.de

Oncology Reports
|February 13, 2003
PubMed

Insights

Meizothrombin (MT) activates renal cell carcinoma (RCC) cells, similar to thrombin, by engaging PAR-1 and PAR-3 receptors. This suggests MT, a thrombin precursor, plays a role in RCC progression.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Meizothrombin (MT), a prothrombin intermediate, activates brain tumor cells via PAR-1 receptors.
  • Its role in renal cell carcinoma (RCC) is not well understood.

Purpose of the Study:

  • To investigate the effect of recombinant human MT (rMT) on calcium mobilization in primary human RCC cultures.
  • To determine the specific thrombin receptors involved in rMT-mediated RCC cell activation.

Main Methods:

  • Primary human RCC cell cultures were established.
  • Calcium mobilization was measured in response to rMT and thrombin stimulation.
  • PAR-type specific antibodies were used to identify involved receptors.

Main Results:

  • rMT rapidly induced transient calcium mobilization in RCC cells, similar to thrombin.
  • Stimulation with thrombin after rMT (and vice versa) did not elicit a new calcium response, indicating shared pathways.
  • PAR-1 and PAR-3 receptors were implicated in rMT-induced calcium signaling.

Conclusions:

  • rMT is a potent activator of human RCC cells.
  • Both thrombin and MT may play significant roles in human renal cell carcinoma.
  • rMT's activation mechanism in RCC involves PAR-1 and PAR-3 receptors.

More Related Videos

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel07:26

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...